557 related articles for article (PubMed ID: 9382880)
1. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells.
Colonna M; Navarro F; Bellón T; Llano M; García P; Samaridis J; Angman L; Cella M; López-Botet M
J Exp Med; 1997 Dec; 186(11):1809-18. PubMed ID: 9382880
[TBL] [Abstract][Full Text] [Related]
2. A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells.
Colonna M; Nakajima H; Navarro F; López-Botet M
J Leukoc Biol; 1999 Sep; 66(3):375-81. PubMed ID: 10496306
[TBL] [Abstract][Full Text] [Related]
3. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules.
Colonna M; Samaridis J; Cella M; Angman L; Allen RL; O'Callaghan CA; Dunbar R; Ogg GS; Cerundolo V; Rolink A
J Immunol; 1998 Apr; 160(7):3096-100. PubMed ID: 9531263
[TBL] [Abstract][Full Text] [Related]
4. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G.
Shiroishi M; Tsumoto K; Amano K; Shirakihara Y; Colonna M; Braud VM; Allan DS; Makadzange A; Rowland-Jones S; Willcox B; Jones EY; van der Merwe PA; Kumagai I; Maenaka K
Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8856-61. PubMed ID: 12853576
[TBL] [Abstract][Full Text] [Related]
5. HLA class I molecules regulate IFN-gamma production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j.
Morel E; Bellón T
J Immunol; 2008 Aug; 181(4):2368-81. PubMed ID: 18684926
[TBL] [Abstract][Full Text] [Related]
6. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules.
Cosman D; Fanger N; Borges L; Kubin M; Chin W; Peterson L; Hsu ML
Immunity; 1997 Aug; 7(2):273-82. PubMed ID: 9285411
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158).
Long EO; Barber DF; Burshtyn DN; Faure M; Peterson M; Rajagopalan S; Renard V; Sandusky M; Stebbins CC; Wagtmann N; Watzl C
Immunol Rev; 2001 Jun; 181():223-33. PubMed ID: 11513144
[TBL] [Abstract][Full Text] [Related]
8. Ig-like transcript 2 (ILT2)/leukocyte Ig-like receptor 1 (LIR1) inhibits TCR signaling and actin cytoskeleton reorganization.
Dietrich J; Cella M; Colonna M
J Immunol; 2001 Feb; 166(4):2514-21. PubMed ID: 11160312
[TBL] [Abstract][Full Text] [Related]
9. Human KIR2DL5 is an inhibitory receptor expressed on the surface of NK and T lymphocyte subsets.
Estefanía E; Flores R; Gómez-Lozano N; Aguilar H; López-Botet M; Vilches C
J Immunol; 2007 Apr; 178(7):4402-10. PubMed ID: 17371997
[TBL] [Abstract][Full Text] [Related]
10. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells.
Avril T; Floyd H; Lopez F; Vivier E; Crocker PR
J Immunol; 2004 Dec; 173(11):6841-9. PubMed ID: 15557178
[TBL] [Abstract][Full Text] [Related]
11. FDF03, a novel inhibitory receptor of the immunoglobulin superfamily, is expressed by human dendritic and myeloid cells.
Fournier N; Chalus L; Durand I; Garcia E; Pin JJ; Churakova T; Patel S; Zlot C; Gorman D; Zurawski S; Abrams J; Bates EE; Garrone P
J Immunol; 2000 Aug; 165(3):1197-209. PubMed ID: 10903717
[TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide stimulates the proliferation of human CD56+CD3- NK cells: a regulatory role of monocytes and IL-10.
Goodier MR; Londei M
J Immunol; 2000 Jul; 165(1):139-47. PubMed ID: 10861046
[TBL] [Abstract][Full Text] [Related]
13. Amoxicillin conjugates to HLA class I molecules and interferes with signalling through the ILT2/LIR-1/CD85j inhibitory receptor.
Morel E; Bellón T
Allergy; 2007 Feb; 62(2):190-6. PubMed ID: 17298429
[TBL] [Abstract][Full Text] [Related]
14. Major histocompatibility complex class I molecules modulate activation threshold and early signaling of T cell antigen receptor-gamma/delta stimulated by nonpeptidic ligands.
Carena I; Shamshiev A; Donda A; Colonna M; Libero GD
J Exp Med; 1997 Nov; 186(10):1769-74. PubMed ID: 9362537
[TBL] [Abstract][Full Text] [Related]
15. A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition.
Michaëlsson J; Teixeira de Matos C; Achour A; Lanier LL; Kärre K; Söderström K
J Exp Med; 2002 Dec; 196(11):1403-14. PubMed ID: 12461076
[TBL] [Abstract][Full Text] [Related]
16. A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing.
Cella M; Döhring C; Samaridis J; Dessing M; Brockhaus M; Lanzavecchia A; Colonna M
J Exp Med; 1997 May; 185(10):1743-51. PubMed ID: 9151699
[TBL] [Abstract][Full Text] [Related]
17. A novel family of inhibitory receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells.
Colonna M; Navarro F; López-Botet M
Curr Top Microbiol Immunol; 1999; 244():115-22. PubMed ID: 10453654
[No Abstract] [Full Text] [Related]
18. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
[TBL] [Abstract][Full Text] [Related]
19. Renal cell carcinoma-infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I allotypes.
Schleypen JS; Von Geldern M; Weiss EH; Kotzias N; Rohrmann K; Schendel DJ; Falk CS; Pohla H
Int J Cancer; 2003 Oct; 106(6):905-12. PubMed ID: 12918068
[TBL] [Abstract][Full Text] [Related]
20. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
Pende D; Sivori S; Accame L; Pareti L; Falco M; Geraghty D; Le Bouteiller P; Moretta L; Moretta A
Eur J Immunol; 1997 Aug; 27(8):1875-80. PubMed ID: 9295021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
